| abstract |
The invention relates to novel hepcidine antagonists of formula (I), pharmaceutical compositions comprising the same, and to the use thereof as medicaments, in particular for treating iron metabolism disorders, for example, iron deficiency diseases and anaemias, in particular anaemias combined with chronic inflammation diseases (ACD; anemia of chronic disease and AI; anemia of inflammation). |